Fenestrated Transcatheter ASD Closure in Adults with Diastolic Dysfunction and/or Pulmonary Hypertension: Case Series and Review of the Literature
- 29 April 2016
- journal article
- review article
- Published by Tech Science Press in Congenital Heart Disease
- Vol. 11 (6) , 663-671
Abstract
This study aims to evaluate the safety and efficacy of transcatheter fenestrated ASD closure and to summarize the literature regarding the published techniques and outcomes of transcatheter partial ASD closure. Patients with left ventricular diastolic dysfunction (LVDD) or right ventricular (RV) dysfunction and/or pulmonary hypertension (PHT) may suffer untoward consequences of complete closure of an ostium secundum atrial septal defect (ASD). Therefore, for patients that fall under these categories we suggest partial occlusion of the defect, which may be better tolerated than complete defect closure. After obtaining IRB approval, a search for patients that have undergone percutaneous ASD closure was performed in the Ahmanson/UCLA Adult Congenital Heart Disease Center database to identify which patients received a fenestrated ASD closure device. Eight consecutive patients ranging between 22 and 83 years of age (mean 48 years) with PHT and/or LVDD or RV dysfunction who underwent fenestrated transcatheter ASD closure at UCLA were identified. None of the subjects experienced complications related to the procedure. Postprocedure clinical evaluation showed improvement in symptoms and exercise capacity. Available follow-up transthoracic echocardiography data (mean 4 months, range 0-20 months) demonstrated patent fenestrations in four of eight patients. None of the patients had thromboembolic or infectious complications and there were no device migrations, erosions or embolizations. Partial ASD occlusion in patients with diastolic dysfunction or RV dysfunction and/or PHT is safe and may be better tolerated than complete ASD closure in selected patients.Keywords
This publication has 24 references indexed in Scilit:
- Shunt reduction with a fenestrated Amplatzer deviceCatheterization and Cardiovascular Interventions, 2010
- Closure of Atrial Septal Defect With the Amplatzer Septal Occluder in AdultsThe American Journal of Cardiology, 2009
- Fenestrated Occluders for Treatment of ASD in Elderly Patients with Pulmonary Hypertension and/or Right Heart FailureJournal of Interventional Cardiology, 2007
- Efficacy and long‐term patency of fenestrated amplatzer devices in childrenCatheterization and Cardiovascular Interventions, 2007
- Transcatheter Closure of Atrial Septal Defects in Adults ≥40 Years of Age: Immediate and Follow‐Up ResultsJournal of Interventional Cardiology, 2007
- Closure of a moderately large atrial septal defect with a self‐fabricated fenestrated Amplatzer septal occluder in an 85‐year‐old patient with reduced diastolic elasticity of the left ventricleCatheterization and Cardiovascular Interventions, 2005
- Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defectCatheterization and Cardiovascular Interventions, 2005
- A new Amplatzer device to maintain patency of Fontan fenestrations and atrial septal defectsCatheterization and Cardiovascular Interventions, 2002
- Do patients over 40 years of age benefit from closure of an atrial septal defect?Heart, 2001
- Atrial septal defect in patients ages 60 years or older: operative results and long-term postoperative follow-up.Circulation, 1981